Catalyst Wire Dossier Catalyst Wire Dossier

CHR-5154

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHR-5154, covering 2017-05-15 to 2017-05-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Dose Escalating Study to Assess Safety, Tolerability, Food Effect and PK of CHR-5154 in Healthy Male Volunteers [Phase 1]

See pricing